Articles

< Previous         Next >  
Atad2 is a generalist facilitator of chromatin dynamics in embryonic stem cells
Yuichi Morozumi1,†, Fayçal Boussouar1,†, Minjia Tan2, Apirat Chaikuad3,4, Mahya Jamshidikia1, Gozde Colak5, Huang He5, Litong Nie2, Carlo Petosa6, Maud de Dieuleveult7, Sandrine Curtet1, Anne-Laure Vitte1, Clothilde Rabatel1, Alexandra Debernardi1, François-Loïc Cosset8, Els Verhoeyen8,9, Anouk Emadali1, Norbert Schweifer10, Davide Gianni10, Marta Gut11, Philippe Guardiola12, Sophie Rousseaux1, Matthieu Gérard7, Stefan Knapp3,4, Yingming Zhao2,5, and Saadi Khochbin1,*
1INSERM, U823; Université Grenoble Alpes; Institut Albert Bonniot Grenoble, F-38700 Grenoble, France
2The Chemical Proteomics Center and State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
3Nuffield Department of Clinical Medicine, University of Oxford, Structural Genomics Consortium, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK
4Nuffield Department of Clinical Medicine, University of Oxford, Target Discovery Institute (TDI), NDM Research Building, Roosevelt Drive, Oxford OX3 7FZ, UK
5Ben May Department of Cancer Research, The University of Chicago, Chicago, IL 60637, USA
6Université Grenoble Alpes/CNRS/CEA, Institut de Biologie Structurale, 38027 Grenoble, France
7Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Univ. Paris-Sud, Université Paris-Saclay, CEN Saclay, 91191 Gif-sur-Yvette, France
8CIRI, International Center for Infectiology Research, EVIR team, INSERM U1111, CNRS, UMR5308, Université de Lyon-1, ENS de Lyon, Lyon, France
9INSERM, U1065, Centre Méditerranéen de Médecine Moléculaire (C3M), équipe ‘contrôle métabolique des morts cellulaires’, Nice 06204, France
10Boehringer-Ingelheim RCV GmbH & Co KG, Dr. Boehringer Gasse 5-11, A-1121 Vienna, Austria
11CNAG–Centre for Genomic Regulation (CRG), Baldiri Reixac 4, 08028 Barcelona; Universitat Pompeu Fabra (UPF), Barcelona, Spain
12INSERM, U892; Centre de Recherche sur le Cancer Nantes Angers and UMR_S 892; Université d'Angers; Plateforme SNP, Transcriptome & Epigénomique; Centre Hospitalier Universitaire d'Angers, Angers 49000, France *Correspondence to:Saadi Khochbin, E-mail: khochbin@ujf-grenoble.fr
J Mol Cell Biol, Volume 8, Issue 4, August 2016, 349-362,  https://doi.org/10.1093/jmcb/mjv060
Keyword: FACT epidrug germ cells cancer drug target histone turnover Pax3 histone chaperone

Although the conserved AAA ATPase and bromodomain factor, ATAD2, has been described as a transcriptional co-activator upregulated in many cancers, its function remains poorly understood. Here, using a combination of ChIP-seq, ChIP-proteomics, and RNA-seq experiments in embryonic stem cells where Atad2 is normally highly expressed, we found that Atad2 is an abundant nucleosome-bound protein present on active genes, associated with chromatin remodelling, DNA replication, and DNA repair factors. A structural analysis of its bromodomain and subsequent investigations demonstrate that histone acetylation guides ATAD2 to chromatin, resulting in an overall increase of chromatin accessibility and histone dynamics, which is required for the proper activity of the highly expressed gene fraction of the genome. While in exponentially growing cells Atad2 appears dispensable for cell growth, in differentiating ES cells Atad2 becomes critical in sustaining specific gene expression programmes, controlling proliferation and differentiation. Altogether, this work defines Atad2 as a facilitator of general chromatin-templated activities such as transcription.